Showing results (131-140 of 205) with videos related to

Sort By:
Pageof 21
Gland Surgery|April 11, 2024
Short-term efficacy and safety of neoadjuvant pyrotinib plus taxanes for early HER2-positive breast cancer: a single-arm exploratory phase II trialGuolin Ye, Peixian Chen, Xiangwei Liu, et al.
American Journal of Clinical Oncology|December 13, 2002
Phase II trial of paclitaxel-epirubicin in patients with recurrent soft-tissue sarcomaXavier Pivot, Christine Chevreau, Didier Cupissol, et al.
Breast (Edinburgh, Scotland)|June 19, 2018
Fluctuation of the left ventricular ejection fraction in patients with HER2-positive early breast cancer treated by 12 months of adjuvant trastuzumabQuentin Jacquinot, Sophie Paget-Bailly, Pierre Fumoleau, et al.
BMC Gastroenterology|August 14, 2014
Advanced biliary tract carcinomas: a retrospective multicenter analysis of first and second-line chemotherapyFrédéric Fiteni, Marine Jary, Franck Monnien, et al.
Breast (Edinburgh, Scotland)|January 12, 2019
Results of PONDx, a prospective multicenter study of the Oncotype DX<sup>®</sup> breast cancer assay: Real-life utilization and decision impact in French clinical practiceElsa Curtit, Jean-Michel Vannetzel, Jean-Claude Darmon, et al.
BMC Cancer|December 19, 2012
Can treatment with Cocculine improve the control of chemotherapy-induced emesis in early breast cancer patients? A randomized, multi-centered, double-blind, placebo-controlled Phase III trialDavid Pérol, Jocelyne Provençal, Anne-Claire Hardy-Bessard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 30, 2009
Randomized phase II trial of first-line trastuzumab plus docetaxel and capecitabine compared with trastuzumab plus docetaxel in HER2-positive metastatic breast cancerAndrew M Wardley, Xavier Pivot, Flavia Morales-Vasquez, et al.
Breast (Edinburgh, Scotland)|February 4, 2011
Discordance in early breast cancer for tumour grade, estrogen receptor, progesteron receptors and human epidermal receptor-2 status between core needle biopsy and surgical excisional primary tumourVeronique Lorgis, Marie Paule Algros, Cristian Villanueva, et al.
Clinical Colorectal Cancer|October 23, 2012
Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancerErion Dobi, Franck Monnien, Stefano Kim, et al.
Pharmacology Research & Perspectives|July 26, 2021
TROIKA-1: A double-blind, randomized, parallel group, study aimed to demonstrate the equivalent pharmacokinetic profile of HD201, a potential biosimilar candidate to trastuzumab, versus EU-Herceptin<sup>®</sup> and US-Herceptin<sup>®</sup> in healthy male subjectsMartin Demarchi, Pierre Coliat, Kristi Mclendon, et al.
Pageof 21